INTERACTION OF HEPARIN WITH LOW-DENSITY LIPOPROTEIN

被引：0
|
作者：
KECSKES, E [1 ]
BUKI, KG [1 ]
机构：
[1] SEMMELWEIS UNIV,SCH MED,INST BIOCHEM 2,H-1444 BUDAPEST,HUNGARY
来源：
ACTA BIOCHIMICA ET BIOPHYSICA HUNGARICA | 1982年 / 17卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [41] Increased circulating oxidised low-density lipoprotein and antibodies to oxidised low-density lipoprotein in preeclampsia
    Arifin, Rosemawati
    Kyi, Win Mar
    Yaakob, Che Anuar Che
    Yaacob, Najib Majdi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 37 (05) : 580 - 584
  • [42] ACTIVATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR SYNTHESIS BY TREATMENT WITH PARTIALLY DELIPIDATED LOW-DENSITY LIPOPROTEIN
    LEUNG, AM
    CHEUNG, WK
    HO, WKK
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1983, 15 (07): : 929 - 934
  • [43] IS VERY LOW-DENSITY LIPOPROTEIN NECESSARY FOR FORMATION OF NORMAL SIZE LOW-DENSITY LIPOPROTEIN POPULATIONS
    DECKELBAUM, R
    OSCHRY, Y
    EISENBERG, S
    CARROLL, R
    RUDEL, L
    ARTERIOSCLEROSIS, 1982, 2 (05): : A437 - A437
  • [44] Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment
    Lahoz, C
    Peña, R
    Mostaza, JM
    Laguna, F
    García-Iglesias, MF
    Taboada, M
    Pintó, X
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (06): : 741 - 747
  • [45] Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
    Katsiki, Niki
    Vrablik, Michal
    Banach, Maciej
    Gouni-Berthold, Ioanna
    PHARMACEUTICALS, 2023, 16 (04)
  • [46] ACTIVATION OF LOW-DENSITY LIPOPROTEIN RECEPTOR SYNTHESIS BY TREATMENT WITH PARTIALLY DELIPIDATED LOW-DENSITY LIPOPROTEIN
    HO, WKK
    LEUNG, AM
    FEDERATION PROCEEDINGS, 1982, 41 (04) : 1217 - 1217
  • [47] Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level
    Matsui, H
    Okumura, K
    Toki, Y
    Hayakawa, T
    DIABETES CARE, 1999, 22 (07) : 1220 - 1221
  • [48] COMPARISON OF GLUCOSYLATED LOW-DENSITY LIPOPROTEIN WITH METHYLATED OR CYCLOHEXANEDIONE-TREATED LOW-DENSITY LIPOPROTEIN IN THE MEASUREMENT OF RECEPTOR-INDEPENDENT LOW-DENSITY LIPOPROTEIN CATABOLISM
    STEINBRECHER, UP
    WITZTUM, JL
    KESANIEMI, YA
    ELAM, R
    ARTERIOSCLEROSIS, 1982, 2 (05): : A444 - A444
  • [49] RADIOTRACERS FOR LOW-DENSITY LIPOPROTEIN BIODISTRIBUTION STUDIES INVIVO - TECHNETIUM-99M LOW-DENSITY LIPOPROTEIN VERSUS RADIOIODINATED LOW-DENSITY LIPOPROTEIN PREPARATIONS
    VALLABHAJOSULA, S
    PAIDI, M
    BADIMON, JJ
    LE, NA
    GOLDSMITH, SJ
    FUSTER, V
    GINSBERG, HN
    JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (07) : 1237 - 1245
  • [50] COMPARISON OF GLUCOSYLATED LOW-DENSITY LIPOPROTEIN WITH METHYLATED OR CYCLOHEXANEDIONE-TREATED LOW-DENSITY LIPOPROTEIN IN THE MEASUREMENT OF RECEPTOR-INDEPENDENT LOW-DENSITY LIPOPROTEIN CATABOLISM
    STEINBRECHER, UP
    WITZTUM, JL
    KESANIEMI, YA
    ELAM, RL
    JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (04): : 960 - 964
12345